Dr. Robin Avery is an infectious disease physician who joined the Johns Hopkins faculty in 2012, with two decades of experience in transplant infectious disease. She is a past chair of the American Society of Transplantation (AST) Infectious Disease Community of Practice, was a co-editor of the first edition of the AST ID Guidelines, and serves on a Guidelines Committee for the Infectious Disease Society of America (IDSA) on immunizations in the immunocompromised host. She was the founding head of the Transplant Infectious Disease Section at the Cleveland Clinic and served as the founding director of the Cleveland Clinic Transplant ID Special Fellowship, authoring a curriculum that served as the basis for curricula later endorsed by the AST and IDSA. Her clinical and research interests include pre-transplant donor and recipient evaluation, and prevention and treatment of post-transplant infections, particularly transplant-associated viruses, viral load monitoring, novel therapies for CMV, hypogammaglobulinemia, immunizations, and strategies for safer living post-transplant. She has a strong interest in patient education and co-authored the script for a video designed to educate patients on decreasing post-transplant infection risks. Dr. Avery is rated as a Distinguished provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Cytomegalic Inclusion Disease, Cytomegalovirus Infection, COVID-19, and Sepsis.

Dr. Erin D. Michos is a Professor of Medicine within the Division of Cardiology at Johns Hopkins School of Medicine, with joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Director of Women's Cardiovascular Health and the Associate Director of Preventive Cardiology within the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. Dr. Michos is an internationally known expert in Preventive Cardiology and Women’s Health, having authored >700 publications and 11 book chapters. Her research involves (1) Women’s Cardiovascular Health; (2) Lipids and Lipid management; (3) Cardio-Kidney-Metabolic and Obesity disease management (4) Coronary artery calcium, inflammation and biomarkers of cardiovascular risk. She is the co-Editor-in-Chief for the American Journal of Preventive Cardiology. She is Co-Director of the IMPACT Center (Improving Participation Among Diverse Populations in Cardiovascular Clinical Trials) at Johns Hopkins, funded by the American Heart Association (AHA). She is a co-investigator in several NIH-funded studies including the Multi-Ethnic Study of Atherosclerosis and Atherosclerosis Risk in Communities cohorts. She has served as the Training Director for four AHA Strategic Focused Research Networks. She has mentored over 60 individuals and the recipient of 2 mentoring awards. Additionally, she was the recipient of the Nanette Wegner Award for Women’s Health Medical Leadership by the Women Heart Organization and the Donna Vogel Women’s Health Champion Award by Johns Hopkins University. Dr. Michos completed medical school at Northwestern University, Internal Medicine residency and Cardiology fellowship at the Johns Hopkins Hospital, and a Masters of Health Science degree at the Johns Hopkins Bloomberg School of Public Health. Dr. Michos is rated as an Advanced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Atherosclerosis, Vitamin D Deficiency, Peripartum Cardiomyopathy, Percutaneous Coronary Intervention (PCI), and Thrombectomy.

Dr. Wendy Post is professor of medicine at the Johns Hopkins University School of Medicine and holds a joint appointment as professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Lou and Nancy Grasmick Professor of Cardiology. Dr. Post is a cardiologist at the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease and the Echocardiography Laboratory and is associate faculty at the Welch Center for Prevention, Epidemiology, and Clinical Research at Johns Hopkins University. She is Director of Cardiovascular Research for the Division of Cardiology and Director of Research for the Hopkins Cardiovascular Fellowship Training Program. Dr. Post received her undergraduate degree in biology from Harvard University. She earned her medical degree from Columbia College of Surgeons and Physicians, Columbia University. After completing her internship and residency at Harvard Medical School’s Beth Israel Hospital, Dr. Post received her master’s degree in epidemiology from the Harvard School of Public Health. She was a research fellow at the Framingham Heart Study, in Framingham, Mass., and completed a fellowship in cardiology at The Johns Hopkins Hospital. Dr. Post joined the Johns Hopkins faculty in 1997. Dr. Post’s research interests include prediction and prevention of coronary heart disease and sudden cardiac death, noninvasive imaging of subclinical atherosclerosis, genetics of cardiovascular disease, sex and racial/ethnic differences in cardiovascular disease, and cardiovascular disease in HIV/AIDS and COVID-19. She is the chair of the steering committee, and the principal investigator for the Hopkins field center for the NIH-funded Multi-Ethnic Study of Atherosclerosis (MESA). Dr. Post also leads Multicenter AIDS Cohort Study (MACS) Cardiovascular Disease sub-studies. She has been the PI for three R01 grants from NHLBI investigating cardiovascular disease in HIV, and is dual PI on the cardiology NHLBI training grant, which has been continuously funded for over 45 years. Dr. Post is a manuscript reviewer for multiple publications and is currently associate editor of Circulation. She has over 350 peer-reviewed research publications. Dr. Post was elected as a member of the American Society for Clinical Investigation (ASCI) in 2015. She mentors multiple medical students, medical house staff, fellows and junior faculty. She was a member of the Hopkins Professorial Promotions Committee and a former Johns Hopkins University Provost Fellow. She was co-chair of the Johns Hopkins University Committee on the Biomedical Scientific Workforce. Dr. Post is rated as an Advanced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Atherosclerosis, Coronary Heart Disease, Carotid Artery Disease, Hormone Replacement Therapy (HRT), and Aortic Valve Replacement.

Dr. Christine Durand, associate professor of medicine and oncology and member of the Johns Hopkins Kimmel Cancer Center, is involved in clinical and translational research focused on individuals infected with HIV and hepatitis C virus who require cancer and transplant therapies. Her current research efforts include looking at outcomes of hepatitis C treatment after solid organ transplant, the potential use of organs from HIV-infected donors for HIV-infected solid organ transplant candidates, and HIV cure strategies including bone marrow transplantation. Dr. Durand is rated as an Advanced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are HIV/AIDS, Hepatitis C, Hepatitis, Tissue Biopsy, and Nephrectomy.

Daniel Brodie is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Brodie is rated as a Distinguished provider by MediFind in the treatment of COVID-19. His top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), COVID-19, Respiratory Acidosis, Lung Transplant, and Embolectomy.

Dr. Allison Hays is a general cardiologist and Medical Director of Echocardiography Programs at the Johns Hopkins Hospital. She is also an assistant professor at the Johns Hopkins University School of Medicine. Dr. Hays graduated from Stanford University with degrees in biology and English. She received her medical training at the Columbia University College of Physicians and Surgeons and did her residency at the New York Presbyterian Hospital at Columbia. Dr. Hays pursued cardiology fellowships at New York University Medical Center and at the Johns Hopkins University School of Medicine. Dr. Hays studies ways to use noninvasive imaging to detect cardiovascular disease. She has advanced multimodality imaging training from Johns Hopkins and attends in the Adult Echocardiography Lab at Johns Hopkins Hospital. In terms of research, she uses Cardiac MRI as a tool to study coronary and systemic endothelial function. Dr. Hays is rated as a Distinguished provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Familial Ventricular Tachycardia, Cardiomyopathy, COVID-19, Heart Attack, and Tissue Biopsy.

Dr. Hager is a specialist in Critical Care Medicine. He is an expert in the diagnosis and management of all forms of acute respiratory failure, including asthma, pneumonia, C.O.P.D., neuromuscular diseases, and the acute respiratory distress syndrome. He also has extensive experience in the management of other life-threatening conditions such as pulmonary embolism, gastrointestinal hemorrhage, shock from sepsis, hypovolemia, and heart disease, and metabolic emergencies such as diabetic ketoacidosis and hyperosmolar states. Dr. Hager is rated as a Distinguished provider by MediFind in the treatment of COVID-19. His top areas of expertise are Severe Acute Respiratory Syndrome (SARS), COVID-19, Acute Respiratory Distress Syndrome (ARDS), and Cerebral Hypoxia.

Mark Sulkowski, MD, is a Professor of Medicine at the Johns Hopkins University School of Medicine and the Director of the Division of Infectious Diseases at Johns Hopkins Bayview Medical Center. He also serves as the Medical Director of the Viral Hepatitis Center in the Divisions of Infectious Diseases and Gastroenterology/Hepatology in the Department of Medicine and is the Senior Associate Dean for Clinical Trials. He received his MD from Temple University School of Medicine, Philadelphia, PA (1992), pursued training in Internal Medicine at Duke University School of Medicine, Durham, NC (1995) and completed his Fellowship in Infectious Diseases (1998) at the Johns Hopkins University School of Medicine. Prof. Sulkowski has been the principal investigator for more than 120 clinical trials related to the management of viral hepatitis B and C in persons with and without HIV co-infection. He was the global principal investigator for more than a dozen trials, including the largest clinical trial of agents for the treatment of hepatitis C (New England Journal of Medicine, 2009) and the vanguard study of combination therapy with direct inhibitors of the HCV NS5A and NS5B non-structural proteins (New England Journal of Medicine, 2014). He is the past-chair of the Hepatitis Transformative Sciences Group of the National Institute of Health-funded adult AIDS Clinical Trials Group (ACTG) where he led translational studies of liver disease, namely hepatitis B and C virus. He is an elected member of the American Society for Clinical Investigation (2011) and the American Association of Physicians (2017). Prof. Sulkowski is a member of numerous professional societies including the American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver (EASL), and the Infectious Diseases Society of America (IDSA). With more than 300 peer-reviewed articles, he is widely published with works in Annals of Internal Medicine, New England Journal of Medicine, JAMA, Clinical Infectious Diseases, Journal of Hepatology, and Hepatology. In 2017, 2018 and 2019, he was named as a Highly Cited Researcher (Clarivate Analytics) defined as the being in the top 1% of global researchers in 21 fields of the sciences and social sciences based on the number of citations for papers. As an invited lecturer, he has been frequently invited to present at major national and international medical congresses and has educated learners in more than 25 countries. Dr. Sulkowski is rated as an Experienced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Hepatitis C, Hepatitis, HIV/AIDS, and Hepatitis B.

Dr. Andrea L. Cox is a professor of Internal Medicine at the Johns Hopkins University School of Medicine in the Division of Infectious Diseases and is a member of the Johns Hopkins Kimmel Cancer Center. She holds joint appointments in Oncology and at the Johns Hopkins Bloomberg School of Public Health, in Molecular Microbiology and Immunology. She is an internationally recognized leader in studies of immune responses in immunocompetent and immunocompromised patient populations to viral infections and vaccines against them, including SARS-Co-V-2 (the virus that causes COVID-19), HIV, hepatitis B virus (HBV) and hepatitis C virus (HCV). Dr. Cox earned her Ph.D. in chemistry from the University of Virginia, where she characterized peptides that drive T cell responses. She then earned her M.D. and completed internal medicine residency and infectious disease fellowship training at Johns Hopkins. She leads the largest prospective cohort study of acute HCV infection, designed to enable detailed molecular analysis of HCV transmission, host immune responses, and virus sequence evolution. She co-led the first prophylactic HCV vaccine trial in individuals at risk of HCV infection. She leads a multidisciplinary international team investigating HCV-specific immune responses to improve vaccine development against HCV, is the lead immunologist on a clinical trial of HBV vaccines in people living with HIV, and co-leads a large team investigating immune responses to COVID-19 infection and vaccines. In addition to her research on viral infections and vaccines, Dr. Cox is actively involved in clinical care of patients with HCV, HIV, and HBV infections. Dr. Cox serves as the director of the Medical Scientist Training Program. A teacher, advisor, and mentor of physician-scientists and scientists, Dr. Cox mentors Ph.D. students in the Johns Hopkins Cellular and Molecular Medicine, Molecular Microbiology and Immunology, and the Immunology graduate training programs. Dr. Cox is rated as an Experienced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Hepatitis C, Hepatitis, COVID-19, and HIV/AIDS.

Dr. Rameen J. Molavi is part-time on the medical faculty as an instructor in medicine in the division of General Internal Medicine within the Department of Medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is internal medicine. Dr. Molavi is also the managing physician and chair of Park Medical Associates, a member of Johns Hopkins Regional Physicians. He is the recipient of the 2025 Samuel P. Asper Award for excellence in medicine from the Maryland Chapter of the American College of Physicians. Dr. Molavi holds a B.A. in biology from Rice University in Houston, TX. He earned his M.D. at the Johns Hopkins University School of Medicine. He completed his internship and residency in categorical internal medicine at the Washington University School of Medicine Barnes-Jewish Hospital in St. Louis, MO. He began medical practice in Lutherville in 1999 and joined Park Medical Associates in 2009. His practice focus is on primary care for adults of all ages. Recent News Articles and Media Coverage Dr. Rameen Molavi: COVID-19 Testing Realities, WYPR (April 28, 2020) Samuel Asper Award, American College of Physicians (2025). Dr. Molavi is rated as an Experienced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Mesenteric Venous Thrombosis, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, and Hypertension.

Dr. Sara Keller graduated from the Duke University School of Medicine in 2007. She completed her Master of Public Health in epidemiology in 2006 at the University of North Carolina at Chapel Hill. She then completed a residency in Internal Medicine in the Osler Medical Residency Training Program at the Johns Hopkins Hospital in 2010, a fellowship in Infectious Diseases at the University of Pennsylvania in 2012, and a fellowship in the University of Pennsylvania Centers for Healthcare Improvement and Patient Safety in 2013. She also completed a Master of Science in Health Policy at the University of Pennsylvania in 2013. She is an Assistant Professor in Infectious Diseases where she primarily sees patients at Johns Hopkins Green Spring Station and also attends on the inpatient infectious disease consult service at the Johns Hopkins Hospital. She serves as the Medical Director of the Johns Hopkins Hospital Outpatient Parenteral Antimicrobial Therapy (OPAT) Service. Dr. Keller is rated as an Experienced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Asymptomatic Bacteriuria, Sepsis, Severe Acute Respiratory Syndrome (SARS), and COVID-19.

Dr. Paul Auwaerter is a professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include Lyme disease, Epstein-Barr virus and fever of unknown origin. Dr. Auwaerter serves as the clinical director of the Division of Infectious Diseases. He is also the director of the Fisher Center for Environmental Infectious Diseases and the chief medical officer of the Point of Care-Information Technology (POC-IT) Center. He earned his M.D. from the Columbia University College of Physicians and Surgeons. His research interests include tick-borne diseases and point of care information technology. Dr. Auwaerter serves on the Clinical Compensation Subcommittee for the Johns Hopkins Department of Medicine. He was recognized with a Healthnetworks Service Excellence Award in 2014. He is a member of the American Society of Microbiology and the Infectious Diseases Society of America. Dr. Auwaerter is rated as an Experienced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Lyme Disease, Infectious Myocarditis, Babesiosis, and Osteomyelitis.

Dr. Michael J. Blaha MD MPH is Professor of Cardiology and Epidemiology and presently serves as the Director of Clinical Research for the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Director of the Cardiometabolic Clinic, and Program Director for the Preventive Cardiology Fellowship. His clinical interests include primary and secondary prevention of cardiovascular disease, with emphasis on early intervention in patients with advanced subclinical atherosclerosis detected with cardiac computed tomography. Dr. Blaha represents the 4th generation of physicians in his family. After earning a BS in pre-medical studies and classical civilization at the University of Notre Dame in 2001, Dr. Blaha went to Vanderbilt University where in 2006 he received his MD as well as an MPH. in clinical epidemiology and biostatistics. Dr. Blaha then completed his Internal Medicine residency in the Osler Medical Housestaff Training Program at Johns Hopkins in 2009 before completing a fellowship in Cardiology at Johns Hopkins in 2012. In 2018, Dr. Blaha received the Dr. Fred Brancati award at Johns Hopkins for excellence in mentoring. He has mentored over 30 trainees, many of which have gone on to hold prominent academic appointments. In 2021, Dr. Blaha was named to the Clarivate Highly Cited Researcher List, representing the top 1% of world’s researchers, and was first named to the Baltimore Magazine Best Doctors List. In 2022, he received the Arthur S. Agatston Cardiovascular Disease Prevention Award. Clinically, he practices as a preventive cardiologist specializing in cardiometabolic disease and in the interpretation of cardiac CT. His clinic specializes in patients with cardiometabolic disease and advanced subclinical atherosclerosis, and the focused use of an array of lifestyle and pharmacotherapies to mitigate that risk. Dr. Blaha is rated as an Experienced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, High Cholesterol, Metabolic Syndrome, and Percutaneous Coronary Intervention (PCI).

Charles Lowenstein, M.D., is a cardiologist in Baltimore, Maryland. He also serves as director of the Division of Cardiology and co-director of the Johns Hopkins Heart and Vascular Institute. Dr. Lowenstein originally came to Johns Hopkins as a cardiology fellow in 1991 after completing his medical residency at Massachusetts General Hospital and a research fellowship at the Massachusetts Institute of Technology. In 1993, he joined the Johns Hopkins faculty and helped lead the Ciccarone Center for the Prevention of Heart Disease until he was recruited in 2009 to become the chief of cardiology and director of the Aab Cardiovascular Research Institute at the University of Rochester School of Medicine and Dentistry. In 2020 he was hired to lead the Division of Cardiology at Hopkins. He has served on the NIH Atherosclerosis and Inflammation Cardiovascular Sciences study section, and is a member of the Sarnoff Cardiovascular Research Foundation, an organization that funds medical student research. Dr. Lowenstein’s research focuses on vascular biology, exploring molecular mechanisms of vascular inflammation and thrombosis. Videos Dr. Charles Lowenstein. Dr. Lowenstein is rated as an Experienced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Long QT Syndrome 3, Heart Attack, Long QT Syndrome 2, Long QT Syndrome 1, and Hormone Replacement Therapy (HRT).

Benjamin Fakheri is a primary care provider, practicing in Internal Medicine in Lutherville, Maryland. Dr. Fakheri is rated as an Experienced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Familial Hypertension, Hypertension, Glucocorticoid-Remediable Aldosteronism, and Splenic Infarction.

Roger Blumenthal is the Kenneth Jay Pollin Professor of Cardiology, professor of medicine and director of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease in Baltimore, Maryland. His principal clinical and research interests involve: 1) strategies to improve cardiovascular risk assessment to identify those adults at elevated risk and those at very low risk of cardiovascular disease and 2) the optimal management of atherosclerotic vascular disease. He is an expert in the pathogenesis, treatment and prevention of atherosclerotic vascular disease. Dr. Blumenthal was the principal developer of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. He is on the official national spokesperson panel for the American Heart Association and has co-written more than 600 articles dealing with many aspects of coronary heart disease and atherosclerosis management. An experienced writer, Dr. Blumenthal is on the editorial board of Circulation, Cardiology Today, and The American College of Cardiology and Extended Learning Center. He is a fellow of the American College of Cardiology and the American Heart Association’s Epidemiology and Prevention Council. He was co-editor-in-chief of the textbook Preventive Cardiology – A Companion to Braunwald’s Heart Disease. He received his medical degree from Cornell Medical College, where he was awarded the Weiss Prize for Excellence in Clinical Medicine. He did his internal medicine and cardiology fellowship training at The Johns Hopkins Hospital before joining the Johns Hopkins cardiology faculty. Dr. Blumenthal was the 2019 recipient of the Landon School Anthony Kupka Distinguished Alumnus Award. He was co-chairperson of the 2019 American College of Cardiology/American Heart Guideline on prevention of cardiovascular disease. Dr. Blumenthal is rated as an Experienced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Metabolic Syndrome, Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.

Dr. Michael T. Melia is an Associate Professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include general infectious diseases, HIV and Lyme disease. He serves as the Director of the Infectious Diseases Fellowship Program. After receiving his medical degree from the Georgetown University School of Medicine, Dr. Melia completed his internal medicine residency, infectious diseases fellowship, and chief medical residency at the Beth Israel Deaconess Medical Center. He joined the Johns Hopkins faculty in 2008. Dr. Melia's academic and research interests center around medical education and coaching in medicine. He is the current Chair of the IDSA Medical Education Community of Practice and is a past Chair of the IDSA Training Program Directors' Committee. In 2015, Dr. Melia was recognized with the Outstanding Achievement in Teaching Award from the Institute for Excellence in Education at the Johns Hopkins University School of Medicine. Dr. Melia is rated as an Experienced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Lyme Disease, Hepatitis C, Allergic Bronchopulmonary Aspergillosis, and HIV/AIDS.

Howard Yang, M.D., practices family medicine at Johns Hopkins Community Physicians Green Spring Station. He received his medical degree from the Washington University School of Medicine, and completed his residency in family medicine at Asylum Hall Family Practice- University of Connecticut. Dr. Yang is rated as an Experienced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Hypertension, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and Thymic Epithelial Tumor.

Stacey-ann Brown is a Pulmonary Medicine provider in Lutherville, Maryland. Dr. Brown is rated as an Experienced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Hypersensitivity Pneumonitis, and Cholesterol Pneumonia.

Dr. Peairs has long standing general internal medicine practice with a specific interest in cancer survivorship and has several clinical leadership roles. In addition to founding the Primary Care for Cancer Survivorship group, she is the Vice Chair for Clinical Affairs and Ambulatory in the Department of Medicine. She is also the Medical Director for Primary Care Value and Innovation in the Office of Johns Hopkins Physicians. She had been the Clinical Director for General Internal Medicine at Greenspring Station for over ten years prior to her present roles. She is a member of the Miller-Coulson Academy for Clinical Excellence at Johns Hopkins University. She is an active member of the Society of General Internal Medicine and American College of Physicians. Dr. Peairs received her medical degree from Johns Hopkins University School of Medicine and went on to complete her internship and residency at The Johns Hopkins Hospital. Dr. Peairs was an assistant chief of service (chief resident) on the Olser Medical Service and joined the faculty in the Division of General Internal Medicine. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Peairs is rated as an Experienced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Breast Cancer, and Juvenile Primary Osteoporosis.